MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7759/cureus.56454

Медицинская библиотека · Cureus · 2024

Typhoid Conjugate Vaccine: A Boon for Endemic Regions.

Agarwal Nitesh, Gupta Naveen, Nishant, H S Surendra, Dutta Trayambak, Mahajan Manish

СтатьяОбзорПеревод в очереди

Аннотация

Typhoid fever has the highest disease burden in countries in low- and middle-income countries, primarily located in Asia and Sub-Saharan Africa. Previous typhoid vaccines such as the live attenuated typhoid (Ty21a) vaccine and Vi (virulence) capsular polysaccharide vaccine had the limitation that they could not be administered with other standard childhood immunizations and were ineffective in children under two years of age. To address these shortcomings of the previous vaccines, typhoid conjugate vaccines (TCVs) were developed and prequalified by the World Health Organization. Cross-reacting material and tetanus toxoid are widely used as carrier proteins in TCVs. According to various studies, TCV has higher efficacy, has a more extended protection period, and is safe and immunogenic in infants as young as six months. This review article aims to comprehensively appraise the data available on TCVs' efficacy, duration of protection, safety, and immunogenicity in endemic regions.

Для цитирования: Agarwal Nitesh, Gupta Naveen, Nishant, H S Surendra, Dutta Trayambak, Mahajan Manish. Typhoid Conjugate Vaccine: A Boon for Endemic Regions.. Cureus. 2024. DOI: 10.7759/cureus.56454.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.